This piece from the National Public Radio discusses the importance of making routine HIV tests more accessible as part of the effort to reach the U.N.’s ambitious goal to eliminate HIV transmission by the year 2030.
It highlights the role of MedAccess and CHAI in supporting Hologic’s affordable testing initiative. It notes that the Hologic platform provides one of the most accurate ways to measure if a patient is responding to anti-retroviral drugs, with the added benefit of also being able to test for hepatitis B and C, as well as HPV.
The article cautions that whilst viral load testing plays a critical role in tackling the HIV epidemic, it will only work where laboratory infrastructure and health system delivery are up to the mark.
Read: NPR’S ARTICLE
MedAccess, CHAI and SD Biosensor announce partnership to make dual rapid test for syphilis and HIV available for under US$1 in over 100 low- and middle-income countries
Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess' Senior Management Team.
MedAccess' volume guarantee will help increase availability of an innovative treatment for latent tuberculosis.